PMV Pharmaceuticals, Inc. (PMVP) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

PMV Pharmaceuticals, Inc. (PMVP) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

PMVP Cash Flow Statement

PMV Pharmaceuticals, Inc. (PMVP) cash flow statement — 8-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-14.58M	-19.68M	-17.19M	-19.82M	-18.3M	-18.27M	-16.66M	-16.84M	-1.6M	-16.18M	-12.09M	-15.66M	-12.9M	-15.01M	-15.32M	-16.76M	-13.68M	-18M	-12.03M	-12.4M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	20.35%	-7.74%	-3.17%	-17.7%	-1045.31%	-12.86%	-37.87%	-7.54%	87.61%	-7.81%	21.14%	6.56%	5.69%	16.59%	-27.4%	-35.17%	-48.03%	-39.48%	-16.64%	-67.7%
Net Income	-18.09M	-18.04M	-18.04M	-21.06M	-21.21M	-17.44M	-23M	-19.23M	-1.21M	-15.27M	-15.76M	-16.64M	-17.44M	-19.13M	-19.34M	-18.23M	-17.31M	-18.43M	-18.36M	-15.01M
Depreciation & Amortization	24K	34K	33K	31K	32K	37K	39K	371K	372K	362K	359K	358K	369K	82K	160K	74K	82K	84K	77K	80K
Stock-Based Compensation	1.54M	1.39M	1.36M	1.38M	1.67M	1.51M	1.27M	2.22M	2.77M	2.61M	2.97M	3.32M	3.15M	0	0	2.45M	2.52M	2.18M	1.77M	1.8M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-1.84M	0	0	0	0	0	0	0	0
Other Non-Cash Items	-360K	-410K	-563K	-697K	-706K	-840K	3.58M	-1.39M	-1.48M	-1.71M	-1.96M	-95K	-1.05M	2.22M	2.52M	-156K	81K	137K	419K	440K
Working Capital Changes	2.3M	-2.66M	13K	522K	1.91M	-1.53M	1.45M	1.18M	-2.05M	-2.17M	2.31M	-764K	2.07M	1.81M	1.34M	-896K	950K	-1.96M	4.07M	297K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	389K	-1.52M	-244K	801K	-995K	-2.99M	4.52M	-2.47M	3.68M	-2.38M	1.55M	-1.81M	2.01M	-1.52M	-1.26M	2.21M	-1.58M	239K	576K	-1.15M
Cash from Investing	-12.23M	20.82M	18.44M	12.03M	10.99M	28.71M	7.74M	17.12M	2.32M	26.17M	-2.59M	-33.64M	-63.96M	49.65M	23.22M	29.51M	-15.28M	-38.83M	7.56M	-693K
Capital Expenditures	0	0	-15K	1K	-11K	-4K	-56K	-1K	-4K	-594K	-197K	-44K	-565K	-156K	-1.64M	-2.05M	-3.5M	-796K	-262K	-501K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	30K	0	0	0	0	0	0	33.59K	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	1K	0	0	222K	29K	0	0	0	-33.59K	0	0	0	0	0	0	0	0
Cash from Financing	143K	0	392K	0	103K	10K	172K	0	141K	0	288K	33.15M	2.13M	12K	548K	6K	276K	128K	295K	309K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	143K	0	392K	0	103K	0	0	0	0	0	288K	33.09M	2.13M	12K	548K	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	10K	172K	0	141K	0	0	51K	0	0	0	6K	276K	128K	295K	309K
Net Change in Cash	-26.66M	1.15M	1.65M	-7.79M	-7.21M	10.46M	-8.76M	284K	872K	9.95M	-14.35M	-16.15M	-74.73M	34.65M	8.45M	12.76M	-28.68M	-56.7M	-4.17M	-12.78M
Free Cash Flow	-14.58M	-19.68M	-17.2M	-19.82M	-18.31M	-18.27M	-16.72M	-16.84M	-1.6M	-16.78M	-12.28M	-15.7M	-13.47M	-15.17M	-16.96M	-18.81M	-17.18M	-18.79M	-12.29M	-12.9M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	20.4%	-7.71%	-2.91%	-17.69%	-1043.13%	-8.89%	-36.11%	-7.24%	88.1%	-10.61%	27.59%	16.51%	21.61%	19.29%	-38.01%	-45.82%	-76.98%	-44.3%	-18.53%	-73.54%
FCF per Share	-0.27	-0.37	-0.32	-0.37	-0.35	-0.35	-0.32	-0.33	-0.03	-0.33	-0.24	-0.32	-0.29	-0.33	-0.37	-0.41	-0.38	-0.41	-0.27	-0.28
FCF Conversion (FCF/Net Income)	0.81x	1.09x	0.95x	0.94x	0.86x	1.05x	0.72x	0.88x	1.32x	1.06x	0.77x	0.94x	0.74x	0.78x	0.79x	0.92x	0.79x	0.98x	0.66x	0.83x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2K	2K	0	19K